<VariationArchive VariationID="962271" VariationName="NM_147127.5(EVC2):c.3080_3107del (p.Lys1027fs)" VariationType="Deletion" Accession="VCV000962271" Version="8" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-01" DateCreated="2020-07-16" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="944093" VariationID="962271">
      <GeneList>
        <Gene Symbol="EVC2" FullName="EvC ciliary complex subunit 2" GeneID="132884" HGNC_ID="HGNC:19747" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>4p16.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="5529011" stop="5709548" display_start="5529011" display_stop="5709548" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="5564145" stop="5711274" display_start="5564145" display_stop="5711274" Strand="-" />
          </Location>
          <OMIM>607261</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_147127.5(EVC2):c.3080_3107del (p.Lys1027fs)</Name>
      <CanonicalSPDI>NC_000004.12:5576404:TCCTGCTGCACCAGCTGGTCCTCCAGCTTCCT:TCCT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>4p16.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="5576405" stop="5576432" display_start="5576405" display_stop="5576432" variantLength="28" positionVCF="5576404" referenceAlleleVCF="CTCCTGCTGCACCAGCTGGTCCTCCAGCT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="5578132" stop="5578159" display_start="5578132" display_stop="5578159" variantLength="28" positionVCF="5578131" referenceAlleleVCF="CTCCTGCTGCACCAGCTGGTCCTCCAGCT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K947fs</ProteinChange>
      <ProteinChange>K1027fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.5578136_5578163del" Assembly="GRCh37">
            <Expression>NC_000004.11:g.5578136_5578163del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.5576409_5576436del" Assembly="GRCh38">
            <Expression>NC_000004.12:g.5576409_5576436del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015821.1" sequenceAccession="NG_015821" sequenceVersion="1" change="g.138117_138144del">
            <Expression>NG_015821.1:g.138117_138144del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001166136.2" sequenceAccession="NM_001166136" sequenceVersion="2" change="c.2840_2867del">
            <Expression>NM_001166136.2:c.2840_2867del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159608.1" sequenceAccession="NP_001159608" sequenceVersion="1" change="p.Lys947fs">
            <Expression>NP_001159608.1:p.Lys947fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_147127.5" sequenceAccession="NM_147127" sequenceVersion="5" change="c.3080_3107del" MANESelect="true">
            <Expression>NM_147127.5:c.3080_3107del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_667338.3" sequenceAccession="NP_667338" sequenceVersion="3" change="p.Lys1027fs">
            <Expression>NP_667338.3:p.Lys1027fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_147127.4" sequenceAccession="NM_147127" sequenceVersion="4" change="c.3080_3107del28">
            <Expression>NM_147127.4:c.3080_3107del28</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1391194715" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_147127.5(EVC2):c.3080_3107del (p.Lys1027fs) AND multiple conditions" Accession="RCV001236098" Version="6">
        <ClassifiedConditionList TraitSetID="10170">
          <ClassifiedCondition DB="MedGen" ID="C0457013">Curry-Hall syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0013903">Ellis-van Creveld syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_147127.5(EVC2):c.3080_3107del (p.Lys1027fs) AND Inborn genetic diseases" Accession="RCV002563846" Version="2">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-10-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-27" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-07-16" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17024374</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19810119</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19876929</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10170" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2081" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Chondroectodermal dysplasia</ElementValue>
                <XRef ID="Ellis-Van+Creveld+Syndrome/2501" DB="Genetic Alliance" />
                <XRef ID="62501005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mesoectodermal dysplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ellis-van Creveld syndrome</ElementValue>
                <XRef ID="MONDO:0009162" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EVC</ElementValue>
                <XRef Type="MIM" ID="225500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1301" />
                <XRef ID="1301" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">37903214</ID>
                <ID Source="BookShelf">NBK596643</ID>
              </Citation>
              <XRef ID="289" DB="Orphanet" />
              <XRef ID="C0013903" DB="MedGen" />
              <XRef ID="MONDO:0009162" DB="MONDO" />
              <XRef Type="MIM" ID="225500" DB="OMIM" />
            </Trait>
            <Trait ID="6119" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Curry-Hall syndrome</ElementValue>
                <XRef ID="277807007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">WEYERS ACRODENTAL DYSOSTOSIS</ElementValue>
                <XRef Type="Allelic variant" ID="604831.0006" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acrofacial dysostosis of Weyers</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">WAD</ElementValue>
                <XRef Type="MIM" ID="193530" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="497" />
                <XRef ID="497" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="952" DB="Orphanet" />
              <XRef ID="C0457013" DB="MedGen" />
              <XRef ID="MONDO:0008673" DB="MONDO" />
              <XRef Type="MIM" ID="193530" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2743846" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="2525265|MedGen:C0457013;C0013903" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001408810" DateUpdated="2024-02-28" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17024374</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19810119</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19876929</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 962271). This variant has not been reported in the literature in individuals affected with EVC2-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Lys1027Argfs*23) in the EVC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EVC2 are known to be pathogenic (PMID: 17024374, 19810119, 19876929).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EVC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.11:g.5578132_5578159del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0457013" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0013903" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6409050" SubmissionDate="2024-04-19" DateLastUpdated="2024-05-01" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="a8249052|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003718855" DateUpdated="2024-05-01" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.3080_3107del28 (p.K1027Rfs*23) alteration, located in exon 18 (coding exon 18) of the EVC2 gene, consists of a deletion of 28 nucleotides from position 3080 to 3107, causing a translational frameshift with a predicted alternate stop codon after 23 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Based on the supporting evidence, this variant is expected to be causative of autosomal recessive Ellis-van Creveld syndrome (AR); however, its clinical significance for autosomal dominant Weyers acrofacial dysostosis (AD) is unclear. Based on data from gnomAD, the EVC2 c.3080_3107del28 (p.L1027Rfs*23) alteration has an overall frequency of &lt;0.01% (2/247046) total alleles studied. The highest observed frequency was 0.01% (2/34246) of Latino/Admixed American alleles. Based on the available evidence, this alteration is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EVC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_147127.4:c.3080_3107del28</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>AVA4 Submission_Through01042023</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2743846" TraitType="Disease" MappingType="XRef" MappingValue="C0013903" MappingRef="MedGen">
        <MedGen CUI="C0013903" Name="Ellis-van Creveld syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2743846" TraitType="Disease" MappingType="XRef" MappingValue="C0457013" MappingRef="MedGen">
        <MedGen CUI="C0457013" Name="Curry-Hall syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6409050" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

